Home
About Us
Subject
Browse
0
Sign In
epidermal growth factor receptor
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases
Article
Year: 2021
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Near infrared photoimmunotherapy for cancers: A translational perspective
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Prediction of EGFR Mutation Status Based on
18
F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study
Article
Year: 2021
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR
-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Interleukin-1β Induces Tissue Factor Expression in A549 Cells via EGFR-Dependent and -Independent Mechanisms
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of
MET
Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair
Article
Year: 2021
Pages: 13
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus
Article
Year: 2020
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (
EGFR
) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in
EGFR
Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR
突变晚期非小细胞肺癌患者后线接受免疫治疗的疗效分析
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Compatibility of intravitreally applied epidermal growth factor and amphiregulin
Article
Year: 2021
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome
Article
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
Article
Year: 2021
Pages: 14
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression
Article
Pages: 9
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Afatinib as First-Line Treatment in Asian Patients with
EGFR
Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
Article
Year: 2021
Pages: 16
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
基于TCGA数据库的
EGFR
突变型与野生型肺腺癌患者免疫微环境的差异性分析
Article
Pages: 9
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Frequency and Prognosis of Epidermal Growth Factor Receptor Variant III Mutations in Glioblastoma Multiforme among Indian Patients: A Single-Institution Study
Article
Year: 2021
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
“Analysis of immunohistochemical expression of epidermal growth factor receptor in oral squamous cell carcinoma using tissue microarray technology and whole sections:” A comparative study
Article
Year: 2021
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Targeting Protein Kinase C in Glioblastoma Treatment
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Gallic acid suppresses colon cancer proliferation by inhibiting SRC and EGFR phosphorylation
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor
Article
Year: 2021
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Long‐term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo
EGFR
T790M: a case report and literature review
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Pembrolizumab Plus Chemotherapy or Anlotinib
vs.
Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population
Article
Year: 2021
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy
Article
Year: 2021
Pages: 17
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Potential Impacts of
Interleukin-17A
Promoter Polymorphisms on the
EGFR
Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Characteristics of T-Cell Receptor Repertoire and Correlation With
EGFR
Mutations in All Stages of Lung Cancer
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
A case of concomitant
EGFR/ALK
alteration against a mutated
EGFR
background in early-stage lung adenocarcinoma
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells
Article
Year: 2021
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Epidermal growth factor receptor intron 1 polymorphism and microsatellite instability in sporadic colorectal cancer
Article
Year: 2020
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer
Article
Year: 2020
Pages: 15
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ameliorates EGF-induced MMP-9 expression by promoting receptor desensitization in MDA-MB-231 cells
Article
Year: 2020
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Overexpression of MIG-6 in the cartilage induces an osteoarthritis-like phenotype in mice
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Analysis of lung biopsies using the 2015 WHO criteria and detection of sensitizing mutations——a single-institution experience of 5032 cases
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
维吾尔族肺腺癌患者的
EGFR
基因突变分析
Article
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
既往吉非替尼治疗获益的晚期NSCLC患者再次使用EGFR-TKI的选择:原药还是换药?
Article
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
成纤维生长因子受体在非小细胞肺癌中的研究进展
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
西妥昔单抗对非小细胞肺癌细胞的体外抑制作用
Article
Pages: 4
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
免疫组化法检测非小细胞肺癌
EGFR
突变的进展
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR
野生型晚期非小细胞肺癌的治疗进展
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
ARMS技术联合Taqman探针检测100例非小细胞肺癌
EGFR
基因突变
Article
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
变性高效液相色谱法检测多种途径获取的非小细胞肺癌组织表皮生长因子受体基因突变
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
非小细胞肺癌原发灶和转移灶EGFR和KRAS状态比较的
meta
分析
Article
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
肺腺癌
EGFR
与
KRAS
基因突变状态分析
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
吉非替尼对肺癌细胞株HCC827和H358放射敏感性的影响及其机制研究
Article
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
细针吸取细胞学标本检测非小细胞肺癌
EGFR
、
KRAS
突变的探讨
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR-TKI一线治疗
EGFR
基因突变的晚期非小细胞肺癌临床观察
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
特异性抗体免疫组化法检测
EGFR
突变价值的
meta
分析
Article
Pages: 9
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
吲哚-3-甲醇对肺癌细胞放射敏感性的EGFR依赖性调节
Article
Pages: 8
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
阿法替尼一线治疗5例晚期肺腺癌患者的不良反应分析及相关文献回顾
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
厄洛替尼致间质性肺病4例并文献复习
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
第三代EGFR-TKIs耐药之初探
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR-TKI治疗非小细胞肺癌中枢神经系统转移的进展
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
同时性多原发肺腺癌的外科治疗及预后
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
晚期NSCLC患者EGFR-TKI治疗过程中血清多肽变化及其临床意义的探索性研究
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR
突变调控肺腺癌PD-L1表达的分子机制研究进展
Article
Pages: 5
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
非小细胞肺癌
EGFR
突变非侵入性检测技术研究进展
Article
Pages: 6
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
EGFR
基因20外显子插入突变在非小细胞肺癌的研究及其进展
Article
Pages: 9
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
微滴数字PCR和Super-ARMS检测晚期肺腺癌患者血浆循环肿瘤DNA表皮生长因子受体基因突变的临床价值研究
Article
Pages: 7
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info